Ying-Ming Tsai

Renowned Medical Doctor and Associate Professor with extensive experience at Kaohsiung Medical University Hospital, adept in medical diagnostics and fostering interdisciplinary collaboration. Excelled in patient care through accurate diagnoses and comprehensive care plans, enhancing patient trust. Proven mentor and researcher, significantly contributing to medical education and clinical practice improvement. Demonstrates exceptional physical examination skills and patient relationship management.

1. Tsai YM, Wu KL, Huang YC, Wu YY, Chang CY, Chang YY, Chiang HH, Liu LX,   Hung JY. (2024, Jan). Upregulated enhancer of rudimentary homolog promotes   epithelial‑mesenchymal transition and cancer cell migration in lung   adenocarcinoma.. Molecular Medicine Reports, Jan;29(1):9.

2. Hsu CC, Tsai YM, Yang SF, Hsu JS. (2023, Sep). Primary pulmonary   meningioma.. Kaohsiung J Med Sci., PMID: 37698283 .

3. Wu YY, Hsu YL, Huang YC, Su YC, Wu KL, Chang CY, Ong CT, Lai JC, Shen   TY, Lee TH, Hung JY, Tsai YM. (2023, Aug). Characterization of the pleural   microenvironment niche and cancer transition using single-cell RNA sequencing   in EGFR-mutated lung cancer. Theranostics, 13(13):4412-4429. MOST   110-2314-B-037-124-MY3. .

4. Huang YC, Hou MF, Tsai YM, Pan YC, Tsai PH, Lin YS, Chang CY, Tsai EM,   Hsu YL. (2023, Jun). Involvement of ACACA (acetyl-CoA carboxylase α) in the   lung pre-metastatic niche formation in breast cancer by senescence phenotypic   conversion in fibroblasts. Cell Oncol (Dordr), 46(3):643-660.

5. Chao-Yuan Chang, Yung-Chi Huang,Hung-Hsing Chiang, Yu-Yuan Wu,Kuan-Li   Wu,Yung-Yun Chang,Lian-Xiu Liu,Ying-Ming Tsai*, and Ya-Ling Hsu (2022, Dec).   Ladinin 1 Shortens Survival via Promoting Proliferation and Enhancing   Invasiveness in Lung Adenocarcinoma. Int. J. Mol.   Sci., 24(1),   431. nstc 110-2314-B-037-124-MY3. 

6. Kuo CY, Tsai MJ, Hung JY, Wu KL, Tsai YM, Tsai YC, Chuang CH, Lee TH,   Chen HC, Yang CJ, Chong IW. (2022, Dec). Different Tyrosine Kinase Inhibitors   Used in Treating EGFR-Mutant Pulmonary Adenocarcinoma with Brain Metastasis   and Intracranial Intervention Have No Impact on Clinical Outcomes. Cancers (Basel), 15(1):187.

7. Yung-Chi Huang, Chao-Yuan Chang, Yu-Yuan Wu, Kuan-Li Wu ,Ying-Ming   Tsai,Hsiao-Chen Lee,Eing-Mei Tsai and Ya-Ling Hsu (2022, Dec). Single-Cell   Transcriptomic Profiles of Lung Pre-Metastatic Niche Reveal Neutrophil and   Lymphatic Endothelial Cell Roles in Breast Cancer. Cancers, 15(1), 176.

8. En-Chi Hsu; Kuan-Li Wu; Ying-Ming Tsai; Mei-Hsuan Lee; Ming-Ju Tsai;   Chia-Yu Kuo; Yu-Chuan Liu; Fu-Wen Liang; Chih-Jen Yang; Jen-Yu Hung (2022,   Oct). Real-world treatment pattern and prognostic factors of stage IV lung   squamous cell carcinoma patients. Kaohsiung   Journal of Medical Sciences, 38(10); 1001-1011. nstc 110-2314-B-037-126-MY2.

9. Kuan-Li Wu, Ying-Ming Tsai, Yung-Chi Huang, Yu-Yuan Wu, Chao-Yuan Chang,   Yu-Wei Liu, Ya-Ling Hsu, Jen-Yu Hung (2022, Oct). LINC02323 facilitates   development of lung squamous cell carcinoma by miRNA sponge and RBP   dysregulation and links to poor prognosis. Thorac   Cancer , doi:   10.1111/1759-7714.14760.

10. Kuan-Li Wu, Yung-Chi Huang, Yu-Yuan Wu, Chao-Yuan Chang, Yung-Yun Chang,   Hung-Hsing Chiang, Lian-Xiu Liu, Ying-Ming Tsai, Jen-Yu Hung (2022, Jun).   Characterization of the Oncogenic Potential of Eukaryotic Initiation Factor   4A1 in Lung Adenocarcinoma via Cell Cycle Regulation and Immune   Microenvironment Reprogramming. Biology (Basel) , 11(7):975..

11. Hsiao-Chen Lee, Chao-Yuan Chang, Kuan-Li Wu, Hung-Hsing Chiang, Yung-Yun   Chang, Lian-Xiu Liu, Yung-Chi Huang, Jen-Yu Hung, Ya-Ling Hsu, Yu-Yuan Wu,   Ying-Ming Tsai (2022, May). The Therapeutic Potential of ADAMTS8 in Lung   Adenocarcinoma without Targetable Therapy. Journal   of personalized medicine , 12(6):902. nstc 110-2314-B-037-124-MY3.

12. Hsiao-Chen Lee, Chao-Yuan Chang, Yung-Chi Huang, Kuan-Li Wu , Hung-Hsing   Chiang, Yung-Yun Chang, Lian-Xiu Liu, Jen-Yu Hung, Ya-Ling Hsu, Yu-Yuan Wu,   Ying-Ming Tsai (2022, May). Downregulated ADAMTS1 Incorporating A2M   Contributes to Tumorigenesis and Alters Tumor Immune Microenvironment in Lung   Adenocarcinoma. Biology (Basel), 11(5):76. nstc   110-2314-B-037-124-MY3. 

13. Wei-An Chang, Ming-Ju Tsai, Jen-Yu Hung , Kuan-Li Wu, Ying-Ming Tsai,   Yung-Chi Huang, Chao-Yuan Chang, Pei-Hsun Tsai, Ya-Ling Hsu (2021, Oct).   miR-150-5p-Containing Extracellular Vesicles Are a New Immunoregulator That   Favor the Progression of Lung Cancer in Hypoxic Microenvironments by Altering   the Phenotype of NK Cells. Cancers (Basel), 13;13(24):6252.

Chao-Yuan Chang, Kuan-Li Wu, Yung-Yun Chang, Pei-Hsun Tsai, Jen-Yu Hung, Wei-An Chang, Shu-Fang Jian, Yung-Chi Huang , Inn-Wen Chong, Ying-Ming Tsai, Ya-Ling Hsu (2021, Sep). Amine oxidase, copper containing 3 exerts anti‑mesenchymal transformation and enhances CD4 + T‑cell recruitment to prolong survival in lung cancer. Oncol Rep, 46(3):203. MOST 110-2314-B-037-124-MY3.